nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2D6—Fingolimod—multiple sclerosis	0.0707	0.202	CbGbCtD
Promethazine—ABCB1—Methylprednisolone—multiple sclerosis	0.0483	0.138	CbGbCtD
Promethazine—CYP2B6—Dexamethasone—multiple sclerosis	0.0357	0.102	CbGbCtD
Promethazine—ABCB1—Mitoxantrone—multiple sclerosis	0.0353	0.101	CbGbCtD
Promethazine—ABCB1—Betamethasone—multiple sclerosis	0.0314	0.0896	CbGbCtD
Promethazine—ABCB1—Prednisolone—multiple sclerosis	0.031	0.0884	CbGbCtD
Promethazine—ABCB1—Prednisone—multiple sclerosis	0.0293	0.0835	CbGbCtD
Promethazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0251	0.141	CbGeAlD
Promethazine—CYP2C9—Dexamethasone—multiple sclerosis	0.0188	0.0537	CbGbCtD
Promethazine—ABCB1—Dexamethasone—multiple sclerosis	0.0183	0.0521	CbGbCtD
Promethazine—CYP2D6—Dexamethasone—multiple sclerosis	0.0172	0.0491	CbGbCtD
Promethazine—ABCB1—Methotrexate—multiple sclerosis	0.0147	0.0419	CbGbCtD
Promethazine—CALM1—trigeminal nerve—multiple sclerosis	0.0108	0.0608	CbGeAlD
Promethazine—CALM2—pons—multiple sclerosis	0.00765	0.043	CbGeAlD
Promethazine—CALM1—pons—multiple sclerosis	0.00761	0.0428	CbGeAlD
Promethazine—HTR2A—trigeminal nerve—multiple sclerosis	0.00659	0.0371	CbGeAlD
Promethazine—CALM2—pineal body—multiple sclerosis	0.00546	0.0307	CbGeAlD
Promethazine—CALM1—pineal body—multiple sclerosis	0.00543	0.0306	CbGeAlD
Promethazine—CALM2—peripheral nervous system—multiple sclerosis	0.00509	0.0286	CbGeAlD
Promethazine—CALM1—peripheral nervous system—multiple sclerosis	0.00506	0.0285	CbGeAlD
Promethazine—HTR2A—pons—multiple sclerosis	0.00464	0.0261	CbGeAlD
Promethazine—CALM2—nerve—multiple sclerosis	0.00397	0.0223	CbGeAlD
Promethazine—CALM1—nerve—multiple sclerosis	0.00395	0.0222	CbGeAlD
Promethazine—DRD2—nerve—multiple sclerosis	0.00365	0.0205	CbGeAlD
Promethazine—HTR2A—pineal body—multiple sclerosis	0.00331	0.0186	CbGeAlD
Promethazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00309	0.0174	CbGeAlD
Promethazine—HTR2A—nerve—multiple sclerosis	0.00241	0.0135	CbGeAlD
Promethazine—CALM3—retina—multiple sclerosis	0.00209	0.0118	CbGeAlD
Promethazine—CHRM4—nervous system—multiple sclerosis	0.00209	0.0117	CbGeAlD
Promethazine—CHRM4—central nervous system—multiple sclerosis	0.00201	0.0113	CbGeAlD
Promethazine—CALM2—brainstem—multiple sclerosis	0.0017	0.00958	CbGeAlD
Promethazine—CALM1—brainstem—multiple sclerosis	0.00169	0.00954	CbGeAlD
Promethazine—CALM2—retina—multiple sclerosis	0.00164	0.00924	CbGeAlD
Promethazine—CALM1—retina—multiple sclerosis	0.00164	0.0092	CbGeAlD
Promethazine—CHRM5—nervous system—multiple sclerosis	0.00163	0.00917	CbGeAlD
Promethazine—ADRA1A—brainstem—multiple sclerosis	0.0016	0.00899	CbGeAlD
Promethazine—CHRM4—brain—multiple sclerosis	0.00159	0.00897	CbGeAlD
Promethazine—CHRM5—central nervous system—multiple sclerosis	0.00157	0.00883	CbGeAlD
Promethazine—DRD2—brainstem—multiple sclerosis	0.00157	0.00881	CbGeAlD
Promethazine—CALM3—medulla oblongata—multiple sclerosis	0.00151	0.00851	CbGeAlD
Promethazine—DRD2—retina—multiple sclerosis	0.00151	0.0085	CbGeAlD
Promethazine—CALM3—midbrain—multiple sclerosis	0.00138	0.00778	CbGeAlD
Promethazine—CALM3—spinal cord—multiple sclerosis	0.00135	0.00759	CbGeAlD
Promethazine—CHRM5—brain—multiple sclerosis	0.00125	0.00701	CbGeAlD
Promethazine—CALM2—medulla oblongata—multiple sclerosis	0.00119	0.00668	CbGeAlD
Promethazine—CALM1—medulla oblongata—multiple sclerosis	0.00118	0.00665	CbGeAlD
Promethazine—CHRM2—nervous system—multiple sclerosis	0.00112	0.0063	CbGeAlD
Promethazine—CALM2—midbrain—multiple sclerosis	0.00109	0.00611	CbGeAlD
Promethazine—CALM1—midbrain—multiple sclerosis	0.00108	0.00608	CbGeAlD
Promethazine—CHRM2—central nervous system—multiple sclerosis	0.00108	0.00606	CbGeAlD
Promethazine—CALM3—cerebellum—multiple sclerosis	0.00107	0.00602	CbGeAlD
Promethazine—CALM2—spinal cord—multiple sclerosis	0.00106	0.00596	CbGeAlD
Promethazine—CALM1—spinal cord—multiple sclerosis	0.00105	0.00593	CbGeAlD
Promethazine—HTR2A—brainstem—multiple sclerosis	0.00103	0.00581	CbGeAlD
Promethazine—CHRM1—nervous system—multiple sclerosis	0.00102	0.00573	CbGeAlD
Promethazine—DRD2—midbrain—multiple sclerosis	0.000998	0.00561	CbGeAlD
Promethazine—HTR2A—retina—multiple sclerosis	0.000996	0.0056	CbGeAlD
Promethazine—CHRM1—central nervous system—multiple sclerosis	0.00098	0.00552	CbGeAlD
Promethazine—CYP2D6—brainstem—multiple sclerosis	0.000941	0.00529	CbGeAlD
Promethazine—CHRM3—nervous system—multiple sclerosis	0.000911	0.00513	CbGeAlD
Promethazine—Euphoric mood—Betamethasone—multiple sclerosis	0.00091	0.00435	CcSEcCtD
Promethazine—Apnoea—Methotrexate—multiple sclerosis	0.000909	0.00435	CcSEcCtD
Promethazine—CALM2—nervous system—multiple sclerosis	0.000892	0.00502	CbGeAlD
Promethazine—CALM1—nervous system—multiple sclerosis	0.000888	0.005	CbGeAlD
Promethazine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.000888	0.00425	CcSEcCtD
Promethazine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.000888	0.00425	CcSEcCtD
Promethazine—Extravasation—Methotrexate—multiple sclerosis	0.000883	0.00423	CcSEcCtD
Promethazine—CHRM3—central nervous system—multiple sclerosis	0.000877	0.00494	CbGeAlD
Promethazine—Anxiety—Cladribine—multiple sclerosis	0.000873	0.00418	CcSEcCtD
Promethazine—CALM3—brain—multiple sclerosis	0.000868	0.00489	CbGeAlD
Promethazine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000865	0.00414	CcSEcCtD
Promethazine—CALM2—central nervous system—multiple sclerosis	0.000859	0.00483	CbGeAlD
Promethazine—Arrhythmia—Azathioprine—multiple sclerosis	0.000858	0.00411	CcSEcCtD
Promethazine—CHRM2—brain—multiple sclerosis	0.000855	0.00481	CbGeAlD
Promethazine—CALM1—central nervous system—multiple sclerosis	0.000855	0.00481	CbGeAlD
Promethazine—Confusional state—Cladribine—multiple sclerosis	0.000846	0.00405	CcSEcCtD
Promethazine—Jaundice—Mitoxantrone—multiple sclerosis	0.000843	0.00404	CcSEcCtD
Promethazine—Oedema—Cladribine—multiple sclerosis	0.000839	0.00402	CcSEcCtD
Promethazine—CALM2—cerebellum—multiple sclerosis	0.000839	0.00472	CbGeAlD
Promethazine—ADRA1A—nervous system—multiple sclerosis	0.000837	0.00471	CbGeAlD
Promethazine—CALM1—cerebellum—multiple sclerosis	0.000836	0.0047	CbGeAlD
Promethazine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000822	0.00393	CcSEcCtD
Promethazine—DRD2—nervous system—multiple sclerosis	0.00082	0.00461	CbGeAlD
Promethazine—Tachycardia—Cladribine—multiple sclerosis	0.000819	0.00392	CcSEcCtD
Promethazine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000807	0.00386	CcSEcCtD
Promethazine—Irritability—Methylprednisolone—multiple sclerosis	0.000807	0.00386	CcSEcCtD
Promethazine—ADRA1A—central nervous system—multiple sclerosis	0.000806	0.00453	CbGeAlD
Promethazine—Euphoric mood—Prednisone—multiple sclerosis	0.000792	0.00379	CcSEcCtD
Promethazine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000791	0.00378	CcSEcCtD
Promethazine—DRD2—central nervous system—multiple sclerosis	0.00079	0.00444	CbGeAlD
Promethazine—ADRA1A—cerebellum—multiple sclerosis	0.000787	0.00443	CbGeAlD
Promethazine—Hypotension—Cladribine—multiple sclerosis	0.000784	0.00375	CcSEcCtD
Promethazine—CHRM1—brain—multiple sclerosis	0.000778	0.00438	CbGeAlD
Promethazine—Thrombophlebitis—Prednisone—multiple sclerosis	0.000773	0.0037	CcSEcCtD
Promethazine—DRD2—cerebellum—multiple sclerosis	0.000772	0.00434	CbGeAlD
Promethazine—Insomnia—Cladribine—multiple sclerosis	0.000759	0.00363	CcSEcCtD
Promethazine—Leukopenia—Azathioprine—multiple sclerosis	0.000749	0.00358	CcSEcCtD
Promethazine—Somnolence—Cladribine—multiple sclerosis	0.000746	0.00357	CcSEcCtD
Promethazine—Irritability—Betamethasone—multiple sclerosis	0.000734	0.00351	CcSEcCtD
Promethazine—Irritability—Dexamethasone—multiple sclerosis	0.000734	0.00351	CcSEcCtD
Promethazine—Asthma—Triamcinolone—multiple sclerosis	0.000732	0.0035	CcSEcCtD
Promethazine—Decreased appetite—Cladribine—multiple sclerosis	0.00073	0.00349	CcSEcCtD
Promethazine—Fatigue—Cladribine—multiple sclerosis	0.000724	0.00346	CcSEcCtD
Promethazine—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000723	0.00346	CcSEcCtD
Promethazine—HTR2A—medulla oblongata—multiple sclerosis	0.00072	0.00405	CbGeAlD
Promethazine—Constipation—Cladribine—multiple sclerosis	0.000718	0.00343	CcSEcCtD
Promethazine—Pain—Cladribine—multiple sclerosis	0.000718	0.00343	CcSEcCtD
Promethazine—Coma—Methotrexate—multiple sclerosis	0.000704	0.00337	CcSEcCtD
Promethazine—CHRM3—brain—multiple sclerosis	0.000697	0.00392	CbGeAlD
Promethazine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000694	0.00332	CcSEcCtD
Promethazine—Feeling abnormal—Cladribine—multiple sclerosis	0.000692	0.00331	CcSEcCtD
Promethazine—CALM2—brain—multiple sclerosis	0.000682	0.00384	CbGeAlD
Promethazine—CALM1—brain—multiple sclerosis	0.000679	0.00382	CbGeAlD
Promethazine—Erythema—Mitoxantrone—multiple sclerosis	0.000676	0.00324	CcSEcCtD
Promethazine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000668	0.0032	CcSEcCtD
Promethazine—CYP2B6—nervous system—multiple sclerosis	0.000663	0.00373	CbGeAlD
Promethazine—HTR2A—midbrain—multiple sclerosis	0.000658	0.0037	CbGeAlD
Promethazine—ABCB1—retina—multiple sclerosis	0.000653	0.00367	CbGeAlD
Promethazine—Bradycardia—Prednisolone—multiple sclerosis	0.000649	0.0031	CcSEcCtD
Promethazine—HRH1—nervous system—multiple sclerosis	0.000648	0.00364	CbGeAlD
Promethazine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000646	0.00309	CcSEcCtD
Promethazine—HTR2A—spinal cord—multiple sclerosis	0.000642	0.00361	CbGeAlD
Promethazine—Ethopropazine—BCHE—multiple sclerosis	0.000641	0.244	CrCbGaD
Promethazine—ADRA1A—brain—multiple sclerosis	0.00064	0.0036	CbGeAlD
Promethazine—Irritability—Prednisone—multiple sclerosis	0.000639	0.00306	CcSEcCtD
Promethazine—CYP2B6—central nervous system—multiple sclerosis	0.000639	0.00359	CbGeAlD
Promethazine—Hypotension—Azathioprine—multiple sclerosis	0.000638	0.00305	CcSEcCtD
Promethazine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000637	0.00305	CcSEcCtD
Promethazine—Photosensitivity—Methotrexate—multiple sclerosis	0.000637	0.00305	CcSEcCtD
Promethazine—DRD2—brain—multiple sclerosis	0.000627	0.00353	CbGeAlD
Promethazine—HRH1—central nervous system—multiple sclerosis	0.000624	0.00351	CbGeAlD
Promethazine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000605	0.0029	CcSEcCtD
Promethazine—Asthenia—Cladribine—multiple sclerosis	0.000602	0.00288	CcSEcCtD
Promethazine—Bradycardia—Triamcinolone—multiple sclerosis	0.000597	0.00285	CcSEcCtD
Promethazine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000595	0.00285	CcSEcCtD
Promethazine—Pruritus—Cladribine—multiple sclerosis	0.000594	0.00284	CcSEcCtD
Promethazine—Convulsion—Mitoxantrone—multiple sclerosis	0.000586	0.0028	CcSEcCtD
Promethazine—Hallucination—Methylprednisolone—multiple sclerosis	0.000582	0.00278	CcSEcCtD
Promethazine—Diarrhoea—Cladribine—multiple sclerosis	0.000574	0.00275	CcSEcCtD
Promethazine—Anxiety—Mitoxantrone—multiple sclerosis	0.000574	0.00274	CcSEcCtD
Promethazine—Arrhythmia—Prednisolone—multiple sclerosis	0.000569	0.00272	CcSEcCtD
Promethazine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000562	0.00269	CcSEcCtD
Promethazine—Confusional state—Mitoxantrone—multiple sclerosis	0.000556	0.00266	CcSEcCtD
Promethazine—Dizziness—Cladribine—multiple sclerosis	0.000555	0.00266	CcSEcCtD
Promethazine—Erythema—Prednisolone—multiple sclerosis	0.000555	0.00265	CcSEcCtD
Promethazine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000552	0.00264	CcSEcCtD
Promethazine—Oedema—Mitoxantrone—multiple sclerosis	0.000552	0.00264	CcSEcCtD
Promethazine—Shock—Mitoxantrone—multiple sclerosis	0.000543	0.0026	CcSEcCtD
Promethazine—Bradycardia—Dexamethasone—multiple sclerosis	0.000541	0.00259	CcSEcCtD
Promethazine—Bradycardia—Betamethasone—multiple sclerosis	0.000541	0.00259	CcSEcCtD
Promethazine—HTR2A—nervous system—multiple sclerosis	0.000541	0.00304	CbGeAlD
Promethazine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00054	0.00259	CcSEcCtD
Promethazine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000539	0.00258	CcSEcCtD
Promethazine—Irritability—Methotrexate—multiple sclerosis	0.000534	0.00255	CcSEcCtD
Promethazine—Rash—Cladribine—multiple sclerosis	0.000529	0.00253	CcSEcCtD
Promethazine—Hallucination—Betamethasone—multiple sclerosis	0.000529	0.00253	CcSEcCtD
Promethazine—Hallucination—Dexamethasone—multiple sclerosis	0.000529	0.00253	CcSEcCtD
Promethazine—Dermatitis—Cladribine—multiple sclerosis	0.000529	0.00253	CcSEcCtD
Promethazine—Headache—Cladribine—multiple sclerosis	0.000526	0.00252	CcSEcCtD
Promethazine—Triflupromazine—BCHE—multiple sclerosis	0.000525	0.2	CrCbGaD
Promethazine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000523	0.0025	CcSEcCtD
Promethazine—Vision blurred—Prednisolone—multiple sclerosis	0.000523	0.0025	CcSEcCtD
Promethazine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000522	0.0025	CcSEcCtD
Promethazine—HTR2A—central nervous system—multiple sclerosis	0.000521	0.00293	CbGeAlD
Promethazine—Hypotension—Mitoxantrone—multiple sclerosis	0.000516	0.00247	CcSEcCtD
Promethazine—Depression—Prednisone—multiple sclerosis	0.000514	0.00246	CcSEcCtD
Promethazine—Erythema—Triamcinolone—multiple sclerosis	0.00051	0.00244	CcSEcCtD
Promethazine—HTR2A—cerebellum—multiple sclerosis	0.000509	0.00286	CbGeAlD
Promethazine—Erythema—Methylprednisolone—multiple sclerosis	0.000509	0.00244	CcSEcCtD
Promethazine—CYP2B6—brain—multiple sclerosis	0.000507	0.00285	CbGeAlD
Promethazine—Syncope—Prednisolone—multiple sclerosis	0.000497	0.00238	CcSEcCtD
Promethazine—HRH1—brain—multiple sclerosis	0.000495	0.00279	CbGeAlD
Promethazine—CYP2D6—nervous system—multiple sclerosis	0.000493	0.00277	CbGeAlD
Promethazine—Somnolence—Mitoxantrone—multiple sclerosis	0.000491	0.00235	CcSEcCtD
Promethazine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000488	0.00233	CcSEcCtD
Promethazine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000486	0.00232	CcSEcCtD
Promethazine—Asthma—Methotrexate—multiple sclerosis	0.000483	0.00231	CcSEcCtD
Promethazine—Convulsion—Prednisolone—multiple sclerosis	0.000481	0.0023	CcSEcCtD
Promethazine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00048	0.0023	CcSEcCtD
Promethazine—Fatigue—Mitoxantrone—multiple sclerosis	0.000476	0.00228	CcSEcCtD
Promethazine—Arrhythmia—Betamethasone—multiple sclerosis	0.000475	0.00227	CcSEcCtD
Promethazine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000475	0.00227	CcSEcCtD
Promethazine—CYP2D6—central nervous system—multiple sclerosis	0.000474	0.00267	CbGeAlD
Promethazine—Constipation—Mitoxantrone—multiple sclerosis	0.000472	0.00226	CcSEcCtD
Promethazine—Pain—Mitoxantrone—multiple sclerosis	0.000472	0.00226	CcSEcCtD
Promethazine—ABCB1—medulla oblongata—multiple sclerosis	0.000472	0.00265	CbGeAlD
Promethazine—Bradycardia—Prednisone—multiple sclerosis	0.000471	0.00226	CcSEcCtD
Promethazine—Diarrhoea—Azathioprine—multiple sclerosis	0.000467	0.00223	CcSEcCtD
Promethazine—CYP2D6—cerebellum—multiple sclerosis	0.000464	0.00261	CbGeAlD
Promethazine—Erythema—Dexamethasone—multiple sclerosis	0.000463	0.00221	CcSEcCtD
Promethazine—Erythema—Betamethasone—multiple sclerosis	0.000463	0.00221	CcSEcCtD
Promethazine—Hallucination—Prednisone—multiple sclerosis	0.000461	0.0022	CcSEcCtD
Promethazine—Syncope—Triamcinolone—multiple sclerosis	0.000457	0.00219	CcSEcCtD
Promethazine—Syncope—Methylprednisolone—multiple sclerosis	0.000456	0.00218	CcSEcCtD
Promethazine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000455	0.00218	CcSEcCtD
Promethazine—Oedema—Prednisolone—multiple sclerosis	0.000453	0.00217	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000453	0.00217	CcSEcCtD
Promethazine—Dizziness—Azathioprine—multiple sclerosis	0.000451	0.00216	CcSEcCtD
Promethazine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000448	0.00215	CcSEcCtD
Promethazine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000447	0.00214	CcSEcCtD
Promethazine—Shock—Prednisolone—multiple sclerosis	0.000445	0.00213	CcSEcCtD
Promethazine—Convulsion—Triamcinolone—multiple sclerosis	0.000442	0.00211	CcSEcCtD
Promethazine—Tachycardia—Prednisolone—multiple sclerosis	0.000442	0.00211	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000441	0.00211	CcSEcCtD
Promethazine—Convulsion—Methylprednisolone—multiple sclerosis	0.000441	0.00211	CcSEcCtD
Promethazine—Anxiety—Methylprednisolone—multiple sclerosis	0.000432	0.00207	CcSEcCtD
Promethazine—ABCB1—midbrain—multiple sclerosis	0.000431	0.00243	CbGeAlD
Promethazine—Drowsiness—Methotrexate—multiple sclerosis	0.000431	0.00206	CcSEcCtD
Promethazine—Rash—Azathioprine—multiple sclerosis	0.00043	0.00206	CcSEcCtD
Promethazine—Dermatitis—Azathioprine—multiple sclerosis	0.00043	0.00206	CcSEcCtD
Promethazine—Depression—Methotrexate—multiple sclerosis	0.00043	0.00206	CcSEcCtD
Promethazine—Headache—Azathioprine—multiple sclerosis	0.000428	0.00205	CcSEcCtD
Promethazine—Dry mouth—Triamcinolone—multiple sclerosis	0.000425	0.00203	CcSEcCtD
Promethazine—ABCB1—spinal cord—multiple sclerosis	0.000421	0.00237	CbGeAlD
Promethazine—Confusional state—Methylprednisolone—multiple sclerosis	0.000419	0.002	CcSEcCtD
Promethazine—Oedema—Triamcinolone—multiple sclerosis	0.000416	0.00199	CcSEcCtD
Promethazine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000416	0.00199	CcSEcCtD
Promethazine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000415	0.00199	CcSEcCtD
Promethazine—Syncope—Dexamethasone—multiple sclerosis	0.000415	0.00199	CcSEcCtD
Promethazine—Syncope—Betamethasone—multiple sclerosis	0.000415	0.00199	CcSEcCtD
Promethazine—Arrhythmia—Prednisone—multiple sclerosis	0.000414	0.00198	CcSEcCtD
Promethazine—HTR2A—brain—multiple sclerosis	0.000413	0.00233	CbGeAlD
Promethazine—Shock—Triamcinolone—multiple sclerosis	0.00041	0.00196	CcSEcCtD
Promethazine—Insomnia—Prednisolone—multiple sclerosis	0.000409	0.00196	CcSEcCtD
Promethazine—Shock—Methylprednisolone—multiple sclerosis	0.000409	0.00196	CcSEcCtD
Promethazine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000407	0.00195	CcSEcCtD
Promethazine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000407	0.00195	CcSEcCtD
Promethazine—Tachycardia—Triamcinolone—multiple sclerosis	0.000406	0.00194	CcSEcCtD
Promethazine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000405	0.00194	CcSEcCtD
Promethazine—Erythema—Prednisone—multiple sclerosis	0.000403	0.00193	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000402	0.00192	CcSEcCtD
Promethazine—Convulsion—Betamethasone—multiple sclerosis	0.000401	0.00192	CcSEcCtD
Promethazine—Convulsion—Dexamethasone—multiple sclerosis	0.000401	0.00192	CcSEcCtD
Promethazine—Asthenia—Mitoxantrone—multiple sclerosis	0.000396	0.00189	CcSEcCtD
Promethazine—Anxiety—Betamethasone—multiple sclerosis	0.000393	0.00188	CcSEcCtD
Promethazine—Anxiety—Dexamethasone—multiple sclerosis	0.000393	0.00188	CcSEcCtD
Promethazine—Hypotension—Methylprednisolone—multiple sclerosis	0.000388	0.00186	CcSEcCtD
Promethazine—Pain—Prednisolone—multiple sclerosis	0.000387	0.00185	CcSEcCtD
Promethazine—Vision blurred—Prednisone—multiple sclerosis	0.00038	0.00182	CcSEcCtD
Promethazine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000378	0.00181	CcSEcCtD
Promethazine—Oedema—Dexamethasone—multiple sclerosis	0.000378	0.00181	CcSEcCtD
Promethazine—Oedema—Betamethasone—multiple sclerosis	0.000378	0.00181	CcSEcCtD
Promethazine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000378	0.00181	CcSEcCtD
Promethazine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000378	0.00181	CcSEcCtD
Promethazine—CYP2D6—brain—multiple sclerosis	0.000377	0.00212	CbGeAlD
Promethazine—Insomnia—Triamcinolone—multiple sclerosis	0.000377	0.0018	CcSEcCtD
Promethazine—Insomnia—Methylprednisolone—multiple sclerosis	0.000376	0.0018	CcSEcCtD
Promethazine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000373	0.00179	CcSEcCtD
Promethazine—Shock—Betamethasone—multiple sclerosis	0.000372	0.00178	CcSEcCtD
Promethazine—Shock—Dexamethasone—multiple sclerosis	0.000372	0.00178	CcSEcCtD
Promethazine—Agitation—Prednisone—multiple sclerosis	0.00037	0.00177	CcSEcCtD
Promethazine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00037	0.00177	CcSEcCtD
Promethazine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00037	0.00177	CcSEcCtD
Promethazine—Tachycardia—Betamethasone—multiple sclerosis	0.000369	0.00176	CcSEcCtD
Promethazine—Tachycardia—Dexamethasone—multiple sclerosis	0.000369	0.00176	CcSEcCtD
Promethazine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000366	0.00175	CcSEcCtD
Promethazine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000366	0.00175	CcSEcCtD
Promethazine—Syncope—Prednisone—multiple sclerosis	0.000361	0.00173	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—multiple sclerosis	0.000361	0.00173	CcSEcCtD
Promethazine—Fatigue—Triamcinolone—multiple sclerosis	0.000359	0.00172	CcSEcCtD
Promethazine—Fatigue—Methylprednisolone—multiple sclerosis	0.000358	0.00171	CcSEcCtD
Promethazine—Pain—Triamcinolone—multiple sclerosis	0.000356	0.0017	CcSEcCtD
Promethazine—ABCB1—nervous system—multiple sclerosis	0.000354	0.00199	CbGeAlD
Promethazine—Loss of consciousness—Prednisone—multiple sclerosis	0.000354	0.0017	CcSEcCtD
Promethazine—Hypotension—Betamethasone—multiple sclerosis	0.000353	0.00169	CcSEcCtD
Promethazine—Hypotension—Dexamethasone—multiple sclerosis	0.000353	0.00169	CcSEcCtD
Promethazine—Convulsion—Prednisone—multiple sclerosis	0.000349	0.00167	CcSEcCtD
Promethazine—Rash—Mitoxantrone—multiple sclerosis	0.000348	0.00166	CcSEcCtD
Promethazine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000348	0.00166	CcSEcCtD
Promethazine—Headache—Mitoxantrone—multiple sclerosis	0.000346	0.00165	CcSEcCtD
Promethazine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000343	0.00164	CcSEcCtD
Promethazine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000342	0.00164	CcSEcCtD
Promethazine—Anxiety—Prednisone—multiple sclerosis	0.000342	0.00164	CcSEcCtD
Promethazine—Insomnia—Betamethasone—multiple sclerosis	0.000342	0.00163	CcSEcCtD
Promethazine—Insomnia—Dexamethasone—multiple sclerosis	0.000342	0.00163	CcSEcCtD
Promethazine—ABCB1—central nervous system—multiple sclerosis	0.000341	0.00192	CbGeAlD
Promethazine—Erythema—Methotrexate—multiple sclerosis	0.000337	0.00161	CcSEcCtD
Promethazine—ABCB1—cerebellum—multiple sclerosis	0.000334	0.00188	CbGeAlD
Promethazine—Dyspepsia—Betamethasone—multiple sclerosis	0.000333	0.00159	CcSEcCtD
Promethazine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000333	0.00159	CcSEcCtD
Promethazine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000329	0.00157	CcSEcCtD
Promethazine—Oedema—Prednisone—multiple sclerosis	0.000329	0.00157	CcSEcCtD
Promethazine—Decreased appetite—Betamethasone—multiple sclerosis	0.000328	0.00157	CcSEcCtD
Promethazine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000328	0.00157	CcSEcCtD
Promethazine—Fatigue—Dexamethasone—multiple sclerosis	0.000326	0.00156	CcSEcCtD
Promethazine—Fatigue—Betamethasone—multiple sclerosis	0.000326	0.00156	CcSEcCtD
Promethazine—Shock—Prednisone—multiple sclerosis	0.000324	0.00155	CcSEcCtD
Promethazine—Pain—Betamethasone—multiple sclerosis	0.000323	0.00155	CcSEcCtD
Promethazine—Pain—Dexamethasone—multiple sclerosis	0.000323	0.00155	CcSEcCtD
Promethazine—Tachycardia—Prednisone—multiple sclerosis	0.000321	0.00154	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—multiple sclerosis	0.000317	0.00152	CcSEcCtD
Promethazine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000311	0.00149	CcSEcCtD
Promethazine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000311	0.00149	CcSEcCtD
Promethazine—Leukopenia—Methotrexate—multiple sclerosis	0.000302	0.00144	CcSEcCtD
Promethazine—Dizziness—Prednisolone—multiple sclerosis	0.000299	0.00143	CcSEcCtD
Promethazine—Asthenia—Triamcinolone—multiple sclerosis	0.000299	0.00143	CcSEcCtD
Promethazine—Asthenia—Methylprednisolone—multiple sclerosis	0.000298	0.00143	CcSEcCtD
Promethazine—Insomnia—Prednisone—multiple sclerosis	0.000298	0.00142	CcSEcCtD
Promethazine—Pruritus—Triamcinolone—multiple sclerosis	0.000295	0.00141	CcSEcCtD
Promethazine—Pruritus—Methylprednisolone—multiple sclerosis	0.000294	0.00141	CcSEcCtD
Promethazine—Convulsion—Methotrexate—multiple sclerosis	0.000292	0.0014	CcSEcCtD
Promethazine—Dyspepsia—Prednisone—multiple sclerosis	0.00029	0.00139	CcSEcCtD
Promethazine—Decreased appetite—Prednisone—multiple sclerosis	0.000286	0.00137	CcSEcCtD
Promethazine—Rash—Prednisolone—multiple sclerosis	0.000285	0.00137	CcSEcCtD
Promethazine—Dermatitis—Prednisolone—multiple sclerosis	0.000285	0.00136	CcSEcCtD
Promethazine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000284	0.00136	CcSEcCtD
Promethazine—Fatigue—Prednisone—multiple sclerosis	0.000284	0.00136	CcSEcCtD
Promethazine—Headache—Prednisolone—multiple sclerosis	0.000284	0.00136	CcSEcCtD
Promethazine—Constipation—Prednisone—multiple sclerosis	0.000281	0.00135	CcSEcCtD
Promethazine—Confusional state—Methotrexate—multiple sclerosis	0.000277	0.00133	CcSEcCtD
Promethazine—Dizziness—Triamcinolone—multiple sclerosis	0.000275	0.00132	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000275	0.00132	CcSEcCtD
Promethazine—Dizziness—Methylprednisolone—multiple sclerosis	0.000275	0.00131	CcSEcCtD
Promethazine—Feeling abnormal—Prednisone—multiple sclerosis	0.000271	0.0013	CcSEcCtD
Promethazine—Asthenia—Dexamethasone—multiple sclerosis	0.000271	0.0013	CcSEcCtD
Promethazine—Asthenia—Betamethasone—multiple sclerosis	0.000271	0.0013	CcSEcCtD
Promethazine—ABCB1—brain—multiple sclerosis	0.000271	0.00152	CbGeAlD
Promethazine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000269	0.00129	CcSEcCtD
Promethazine—Pruritus—Dexamethasone—multiple sclerosis	0.000267	0.00128	CcSEcCtD
Promethazine—Pruritus—Betamethasone—multiple sclerosis	0.000267	0.00128	CcSEcCtD
Promethazine—Oxcarbazepine—ALB—multiple sclerosis	0.000264	0.1	CrCbGaD
Promethazine—Rash—Triamcinolone—multiple sclerosis	0.000262	0.00126	CcSEcCtD
Promethazine—Dermatitis—Triamcinolone—multiple sclerosis	0.000262	0.00125	CcSEcCtD
Promethazine—Rash—Methylprednisolone—multiple sclerosis	0.000262	0.00125	CcSEcCtD
Promethazine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000262	0.00125	CcSEcCtD
Promethazine—Headache—Triamcinolone—multiple sclerosis	0.000261	0.00125	CcSEcCtD
Promethazine—Headache—Methylprednisolone—multiple sclerosis	0.00026	0.00125	CcSEcCtD
Promethazine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000258	0.00124	CcSEcCtD
Promethazine—Diarrhoea—Betamethasone—multiple sclerosis	0.000258	0.00124	CcSEcCtD
Promethazine—Hypotension—Methotrexate—multiple sclerosis	0.000257	0.00123	CcSEcCtD
Promethazine—Chlorpromazine—BCHE—multiple sclerosis	0.000253	0.0964	CrCbGaD
Promethazine—Dizziness—Dexamethasone—multiple sclerosis	0.00025	0.0012	CcSEcCtD
Promethazine—Dizziness—Betamethasone—multiple sclerosis	0.00025	0.0012	CcSEcCtD
Promethazine—Insomnia—Methotrexate—multiple sclerosis	0.000249	0.00119	CcSEcCtD
Promethazine—Somnolence—Methotrexate—multiple sclerosis	0.000244	0.00117	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—multiple sclerosis	0.000242	0.00116	CcSEcCtD
Promethazine—Decreased appetite—Methotrexate—multiple sclerosis	0.000239	0.00114	CcSEcCtD
Promethazine—Rash—Betamethasone—multiple sclerosis	0.000238	0.00114	CcSEcCtD
Promethazine—Rash—Dexamethasone—multiple sclerosis	0.000238	0.00114	CcSEcCtD
Promethazine—Dermatitis—Betamethasone—multiple sclerosis	0.000238	0.00114	CcSEcCtD
Promethazine—Dermatitis—Dexamethasone—multiple sclerosis	0.000238	0.00114	CcSEcCtD
Promethazine—Fatigue—Methotrexate—multiple sclerosis	0.000237	0.00113	CcSEcCtD
Promethazine—Headache—Betamethasone—multiple sclerosis	0.000237	0.00113	CcSEcCtD
Promethazine—Headache—Dexamethasone—multiple sclerosis	0.000237	0.00113	CcSEcCtD
Promethazine—Asthenia—Prednisone—multiple sclerosis	0.000236	0.00113	CcSEcCtD
Promethazine—Pain—Methotrexate—multiple sclerosis	0.000235	0.00112	CcSEcCtD
Promethazine—Pruritus—Prednisone—multiple sclerosis	0.000233	0.00111	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000227	0.00108	CcSEcCtD
Promethazine—Diarrhoea—Prednisone—multiple sclerosis	0.000225	0.00108	CcSEcCtD
Promethazine—Dizziness—Prednisone—multiple sclerosis	0.000218	0.00104	CcSEcCtD
Promethazine—Rash—Prednisone—multiple sclerosis	0.000207	0.000992	CcSEcCtD
Promethazine—Dermatitis—Prednisone—multiple sclerosis	0.000207	0.000992	CcSEcCtD
Promethazine—Headache—Prednisone—multiple sclerosis	0.000206	0.000986	CcSEcCtD
Promethazine—Acepromazine—ALB—multiple sclerosis	0.000199	0.0759	CrCbGaD
Promethazine—Asthenia—Methotrexate—multiple sclerosis	0.000197	0.000944	CcSEcCtD
Promethazine—Thioproperazine—ALB—multiple sclerosis	0.000195	0.0742	CrCbGaD
Promethazine—Pruritus—Methotrexate—multiple sclerosis	0.000195	0.000931	CcSEcCtD
Promethazine—Pipotiazine—ALB—multiple sclerosis	0.000192	0.073	CrCbGaD
Promethazine—Diarrhoea—Methotrexate—multiple sclerosis	0.000188	0.0009	CcSEcCtD
Promethazine—Dizziness—Methotrexate—multiple sclerosis	0.000182	0.00087	CcSEcCtD
Promethazine—Rash—Methotrexate—multiple sclerosis	0.000173	0.000829	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—multiple sclerosis	0.000173	0.000829	CcSEcCtD
Promethazine—Headache—Methotrexate—multiple sclerosis	0.000172	0.000824	CcSEcCtD
Promethazine—Clomipramine—ALB—multiple sclerosis	0.000152	0.0577	CrCbGaD
Promethazine—Chlorpromazine—ALB—multiple sclerosis	0.000104	0.0396	CrCbGaD
Promethazine—Amitriptyline—ALB—multiple sclerosis	0.000103	0.0391	CrCbGaD
Promethazine—CALM2—Disease—CD80—multiple sclerosis	1.56e-05	6e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CD80—multiple sclerosis	1.56e-05	6e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—MAPK1—multiple sclerosis	1.56e-05	5.99e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—MAPK1—multiple sclerosis	1.56e-05	5.99e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CD86—multiple sclerosis	1.55e-05	5.95e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.53e-05	5.9e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—POMC—multiple sclerosis	1.53e-05	5.89e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.53e-05	5.88e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCL5—multiple sclerosis	1.52e-05	5.86e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.5e-05	5.78e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.5e-05	5.77e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CD86—multiple sclerosis	1.5e-05	5.76e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CD86—multiple sclerosis	1.5e-05	5.76e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.5e-05	5.75e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—APOE—multiple sclerosis	1.49e-05	5.74e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.49e-05	5.73e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.48e-05	5.68e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—IL6—multiple sclerosis	1.48e-05	5.68e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—TYK2—multiple sclerosis	1.47e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCL5—multiple sclerosis	1.47e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCL5—multiple sclerosis	1.47e-05	5.67e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.47e-05	5.66e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—APOE—multiple sclerosis	1.44e-05	5.55e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—APOE—multiple sclerosis	1.44e-05	5.55e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—TYK2—multiple sclerosis	1.42e-05	5.48e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—TYK2—multiple sclerosis	1.42e-05	5.48e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SPP1—multiple sclerosis	1.41e-05	5.43e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	1.41e-05	5.42e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	1.4e-05	5.39e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ALB—multiple sclerosis	1.4e-05	5.37e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.38e-05	5.32e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IFNG—multiple sclerosis	1.38e-05	5.31e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCR5—multiple sclerosis	1.37e-05	5.28e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SPP1—multiple sclerosis	1.36e-05	5.25e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SPP1—multiple sclerosis	1.36e-05	5.25e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TYK2—multiple sclerosis	1.36e-05	5.23e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	5.23e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	5.22e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.35e-05	5.2e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	1.35e-05	5.2e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.35e-05	5.19e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.35e-05	5.19e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.34e-05	5.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL2—multiple sclerosis	1.34e-05	5.16e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	5.13e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IFNG—multiple sclerosis	1.33e-05	5.13e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IFNG—multiple sclerosis	1.33e-05	5.13e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	1.33e-05	5.13e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD4—multiple sclerosis	1.33e-05	5.13e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	5.12e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCR5—multiple sclerosis	1.33e-05	5.11e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCR5—multiple sclerosis	1.33e-05	5.11e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.32e-05	5.07e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TYK2—multiple sclerosis	1.32e-05	5.06e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TYK2—multiple sclerosis	1.32e-05	5.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.31e-05	5.05e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	1.31e-05	5.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	1.31e-05	5.03e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL2—multiple sclerosis	1.3e-05	4.99e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL2—multiple sclerosis	1.3e-05	4.99e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	4.97e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD4—multiple sclerosis	1.29e-05	4.96e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD4—multiple sclerosis	1.29e-05	4.96e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	4.96e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.28e-05	4.94e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.28e-05	4.94e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—POMC—multiple sclerosis	1.28e-05	4.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.28e-05	4.93e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.28e-05	4.91e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.27e-05	4.88e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.26e-05	4.87e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.26e-05	4.86e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.26e-05	4.85e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.26e-05	4.84e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.26e-05	4.83e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.25e-05	4.82e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—APOE—multiple sclerosis	1.25e-05	4.8e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.24e-05	4.77e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—POMC—multiple sclerosis	1.24e-05	4.77e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—POMC—multiple sclerosis	1.24e-05	4.77e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	1.24e-05	4.76e-05	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—IL6—multiple sclerosis	1.24e-05	4.76e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	4.76e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	1.23e-05	4.75e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL1B—multiple sclerosis	1.23e-05	4.73e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—CD4—multiple sclerosis	1.23e-05	4.73e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.23e-05	4.73e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL2—multiple sclerosis	1.23e-05	4.72e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.23e-05	4.72e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	4.67e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	4.66e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—APOE—multiple sclerosis	1.21e-05	4.64e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—APOE—multiple sclerosis	1.21e-05	4.64e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.2e-05	4.62e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—IL6—multiple sclerosis	1.2e-05	4.6e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—IL6—multiple sclerosis	1.2e-05	4.6e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL1B—multiple sclerosis	1.19e-05	4.58e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL1B—multiple sclerosis	1.19e-05	4.58e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CD4—multiple sclerosis	1.19e-05	4.58e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—CD4—multiple sclerosis	1.19e-05	4.58e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL2—multiple sclerosis	1.19e-05	4.56e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL2—multiple sclerosis	1.19e-05	4.56e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	1.19e-05	4.56e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ALB—multiple sclerosis	1.17e-05	4.5e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.17e-05	4.49e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	4.41e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.14e-05	4.41e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.14e-05	4.39e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.14e-05	4.38e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.13e-05	4.37e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—APOE—multiple sclerosis	1.13e-05	4.35e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ALB—multiple sclerosis	1.13e-05	4.35e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ALB—multiple sclerosis	1.13e-05	4.35e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CD80—multiple sclerosis	1.13e-05	4.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.13e-05	4.33e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	1.12e-05	4.32e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	1.1e-05	4.24e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-05	4.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CD80—multiple sclerosis	1.09e-05	4.2e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CD80—multiple sclerosis	1.09e-05	4.2e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-05	4.15e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—POMC—multiple sclerosis	1.07e-05	4.12e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.07e-05	4.1e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—APOE—multiple sclerosis	1.06e-05	4.07e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.05e-05	4.06e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.05e-05	4.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCL2—multiple sclerosis	1.05e-05	4.04e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	3.99e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	3.99e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.03e-05	3.97e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—STAT3—multiple sclerosis	1.03e-05	3.97e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.03e-05	3.95e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCL2—multiple sclerosis	1.01e-05	3.9e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCL2—multiple sclerosis	1.01e-05	3.9e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—STAT3—multiple sclerosis	9.98e-06	3.84e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—STAT3—multiple sclerosis	9.98e-06	3.84e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	9.93e-06	3.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	9.93e-06	3.82e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—POMC—multiple sclerosis	9.72e-06	3.74e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	9.7e-06	3.73e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	9.65e-06	3.71e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	9.55e-06	3.67e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	9.53e-06	3.67e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TYK2—multiple sclerosis	9.52e-06	3.66e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—STAT3—multiple sclerosis	9.52e-06	3.66e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	9.5e-06	3.66e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	9.5e-06	3.65e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	9.48e-06	3.65e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	9.47e-06	3.64e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	9.45e-06	3.64e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	9.42e-06	3.62e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—MAPK1—multiple sclerosis	9.38e-06	3.61e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.37e-06	3.61e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	9.35e-06	3.6e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.33e-06	3.59e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	9.3e-06	3.58e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TYK2—multiple sclerosis	9.21e-06	3.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TYK2—multiple sclerosis	9.21e-06	3.55e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—STAT3—multiple sclerosis	9.21e-06	3.54e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—STAT3—multiple sclerosis	9.21e-06	3.54e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	9.18e-06	3.53e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—POMC—multiple sclerosis	9.16e-06	3.52e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—POMC—multiple sclerosis	9.08e-06	3.49e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—MAPK1—multiple sclerosis	9.07e-06	3.49e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—MAPK1—multiple sclerosis	9.07e-06	3.49e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	9.04e-06	3.48e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	9.02e-06	3.47e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	8.99e-06	3.46e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	8.96e-06	3.45e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.87e-06	3.41e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ALB—multiple sclerosis	8.86e-06	3.41e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—multiple sclerosis	8.85e-06	3.41e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	8.85e-06	3.4e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—TGFB1—multiple sclerosis	8.83e-06	3.4e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK1—multiple sclerosis	8.66e-06	3.33e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—multiple sclerosis	8.56e-06	3.29e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—multiple sclerosis	8.56e-06	3.29e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—multiple sclerosis	8.54e-06	3.29e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—multiple sclerosis	8.54e-06	3.29e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK1—multiple sclerosis	8.37e-06	3.22e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK1—multiple sclerosis	8.37e-06	3.22e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—multiple sclerosis	8.35e-06	3.21e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	8.28e-06	3.19e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—multiple sclerosis	8.27e-06	3.18e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	8.16e-06	3.14e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	8.03e-06	3.09e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	8.02e-06	3.08e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	7.99e-06	3.07e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	7.97e-06	3.06e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	7.93e-06	3.05e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—multiple sclerosis	7.92e-06	3.05e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.89e-06	3.04e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—multiple sclerosis	7.89e-06	3.03e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	7.87e-06	3.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—multiple sclerosis	7.67e-06	2.95e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—multiple sclerosis	7.67e-06	2.95e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—multiple sclerosis	7.63e-06	2.94e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—multiple sclerosis	7.63e-06	2.94e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	7.59e-06	2.92e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	7.57e-06	2.91e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—multiple sclerosis	7.5e-06	2.89e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	7.46e-06	2.87e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	7.45e-06	2.87e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	7.45e-06	2.87e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	7.43e-06	2.86e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	7.42e-06	2.86e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	7.42e-06	2.86e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.41e-06	2.85e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	7.4e-06	2.85e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	7.38e-06	2.84e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.33e-06	2.82e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.31e-06	2.81e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	7.31e-06	2.81e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	7.3e-06	2.81e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	7.29e-06	2.81e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	7.29e-06	2.8e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.26e-06	2.8e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—multiple sclerosis	7.26e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—multiple sclerosis	7.26e-06	2.79e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.24e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—multiple sclerosis	7.2e-06	2.77e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.17e-06	2.76e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	7.15e-06	2.75e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—multiple sclerosis	6.97e-06	2.68e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—multiple sclerosis	6.97e-06	2.68e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—multiple sclerosis	6.67e-06	2.57e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—multiple sclerosis	6.65e-06	2.56e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—multiple sclerosis	6.45e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—multiple sclerosis	6.45e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—multiple sclerosis	6.43e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—multiple sclerosis	6.43e-06	2.48e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—multiple sclerosis	6.2e-06	2.38e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	6.18e-06	2.38e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	6.06e-06	2.33e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—multiple sclerosis	5.99e-06	2.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—multiple sclerosis	5.99e-06	2.31e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	5.98e-06	2.3e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	5.98e-06	2.3e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	5.86e-06	2.26e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	5.86e-06	2.26e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.7e-06	2.19e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5.61e-06	2.16e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	5.6e-06	2.15e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	5.58e-06	2.15e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	5.56e-06	2.14e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.51e-06	2.12e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	5.49e-06	2.11e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—multiple sclerosis	4.66e-06	1.79e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—multiple sclerosis	4.51e-06	1.73e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—multiple sclerosis	4.51e-06	1.73e-05	CbGpPWpGaD
